Cargando…
Use of volatile agents for sedation in the intensive care unit: A national survey in France
BACKGROUND: Current intensive care unit (ICU) sedation guidelines recommend strategies using non-benzodiazepine sedatives. This survey was undertaken to explore inhaled ICU sedation practice in France. METHODS: In this national survey, medical directors of French adult ICUs were contacted by phone o...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049230/ https://www.ncbi.nlm.nih.gov/pubmed/33857185 http://dx.doi.org/10.1371/journal.pone.0249889 |
_version_ | 1783679387975024640 |
---|---|
author | Blondonnet, Raiko Quinson, Audrey Lambert, Céline Audard, Jules Godet, Thomas Zhai, Ruoyang Pereira, Bruno Futier, Emmanuel Bazin, Jean-Etienne Constantin, Jean-Michel Jabaudon, Matthieu |
author_facet | Blondonnet, Raiko Quinson, Audrey Lambert, Céline Audard, Jules Godet, Thomas Zhai, Ruoyang Pereira, Bruno Futier, Emmanuel Bazin, Jean-Etienne Constantin, Jean-Michel Jabaudon, Matthieu |
author_sort | Blondonnet, Raiko |
collection | PubMed |
description | BACKGROUND: Current intensive care unit (ICU) sedation guidelines recommend strategies using non-benzodiazepine sedatives. This survey was undertaken to explore inhaled ICU sedation practice in France. METHODS: In this national survey, medical directors of French adult ICUs were contacted by phone or email between July and August 2019. ICU medical directors were questioned about the characteristics of their department, their knowledge on inhaled sedation, and practical aspects of inhaled sedation use in their department. RESULTS: Among the 374 ICUs contacted, 187 provided responses (50%). Most ICU directors (73%) knew about the use of inhaled ICU sedation and 21% used inhaled sedation in their unit, mostly with the Anaesthetic Conserving Device (AnaConDa, Sedana Medical). Most respondents had used volatile agents for sedation for <5 years (63%) and in <20 patients per year (75%), with their main indications being: failure of intravenous sedation, severe asthma or bronchial obstruction, and acute respiratory distress syndrome. Sevoflurane and isoflurane were mainly used (88% and 20%, respectively). The main reasons for not using inhaled ICU sedation were: “device not available” (40%), “lack of medical interest” (37%), “lack of familiarity or knowledge about the technique” (35%) and “elevated cost” (21%). Most respondents (80%) were overall satisfied with the use of inhaled sedation. Almost 75% stated that inhaled sedation was a seducing alternative to intravenous sedation. CONCLUSION: This survey highlights the widespread knowledge about inhaled ICU sedation in France but shows its limited use to date. Differences in education and knowledge, as well as the recent and relatively scarce literature on the use of volatile agents in the ICU, might explain the diverse practices that were observed. The low rate of mild adverse effects, as perceived by respondents, and the users’ satisfaction, are promising for this potentially important tool for ICU sedation. |
format | Online Article Text |
id | pubmed-8049230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-80492302021-04-21 Use of volatile agents for sedation in the intensive care unit: A national survey in France Blondonnet, Raiko Quinson, Audrey Lambert, Céline Audard, Jules Godet, Thomas Zhai, Ruoyang Pereira, Bruno Futier, Emmanuel Bazin, Jean-Etienne Constantin, Jean-Michel Jabaudon, Matthieu PLoS One Research Article BACKGROUND: Current intensive care unit (ICU) sedation guidelines recommend strategies using non-benzodiazepine sedatives. This survey was undertaken to explore inhaled ICU sedation practice in France. METHODS: In this national survey, medical directors of French adult ICUs were contacted by phone or email between July and August 2019. ICU medical directors were questioned about the characteristics of their department, their knowledge on inhaled sedation, and practical aspects of inhaled sedation use in their department. RESULTS: Among the 374 ICUs contacted, 187 provided responses (50%). Most ICU directors (73%) knew about the use of inhaled ICU sedation and 21% used inhaled sedation in their unit, mostly with the Anaesthetic Conserving Device (AnaConDa, Sedana Medical). Most respondents had used volatile agents for sedation for <5 years (63%) and in <20 patients per year (75%), with their main indications being: failure of intravenous sedation, severe asthma or bronchial obstruction, and acute respiratory distress syndrome. Sevoflurane and isoflurane were mainly used (88% and 20%, respectively). The main reasons for not using inhaled ICU sedation were: “device not available” (40%), “lack of medical interest” (37%), “lack of familiarity or knowledge about the technique” (35%) and “elevated cost” (21%). Most respondents (80%) were overall satisfied with the use of inhaled sedation. Almost 75% stated that inhaled sedation was a seducing alternative to intravenous sedation. CONCLUSION: This survey highlights the widespread knowledge about inhaled ICU sedation in France but shows its limited use to date. Differences in education and knowledge, as well as the recent and relatively scarce literature on the use of volatile agents in the ICU, might explain the diverse practices that were observed. The low rate of mild adverse effects, as perceived by respondents, and the users’ satisfaction, are promising for this potentially important tool for ICU sedation. Public Library of Science 2021-04-15 /pmc/articles/PMC8049230/ /pubmed/33857185 http://dx.doi.org/10.1371/journal.pone.0249889 Text en © 2021 Blondonnet et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Blondonnet, Raiko Quinson, Audrey Lambert, Céline Audard, Jules Godet, Thomas Zhai, Ruoyang Pereira, Bruno Futier, Emmanuel Bazin, Jean-Etienne Constantin, Jean-Michel Jabaudon, Matthieu Use of volatile agents for sedation in the intensive care unit: A national survey in France |
title | Use of volatile agents for sedation in the intensive care unit: A national survey in France |
title_full | Use of volatile agents for sedation in the intensive care unit: A national survey in France |
title_fullStr | Use of volatile agents for sedation in the intensive care unit: A national survey in France |
title_full_unstemmed | Use of volatile agents for sedation in the intensive care unit: A national survey in France |
title_short | Use of volatile agents for sedation in the intensive care unit: A national survey in France |
title_sort | use of volatile agents for sedation in the intensive care unit: a national survey in france |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049230/ https://www.ncbi.nlm.nih.gov/pubmed/33857185 http://dx.doi.org/10.1371/journal.pone.0249889 |
work_keys_str_mv | AT blondonnetraiko useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT quinsonaudrey useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT lambertceline useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT audardjules useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT godetthomas useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT zhairuoyang useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT pereirabruno useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT futieremmanuel useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT bazinjeanetienne useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT constantinjeanmichel useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance AT jabaudonmatthieu useofvolatileagentsforsedationintheintensivecareunitanationalsurveyinfrance |